Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: allen menglin chen who wrote (375)	5/16/2000 7:13:00 PM
From: gao seng	Read Replies (1) \| Respond to of 746

Good news is definitely coming, and it will be huge! Who knows, maybe they will have the mouse genome done by early June as well, so they can settle this bet: (excerpt from link) Gentlemen, Place Your Bets: Well, they weren't all men, but mostly. The betting in the pub continued, the lowest bet being 29,800 genes placed by Pat Tome and the highest number coming from John Quackenbush at 118,259. The pool was organized by Erwin Birney, a team leader at the European Bioinformatics Institute. He tried to convince the bartender to oversee the betting, but was told in no uncertain terms that no gambling was allowed in the Cold Spring bar. Guesses on the number of genes in the human genome have lowered considerably since the mapping of chromosome 21, which researchers found to contain only 225 genes, far fewer than previously predicted. The researchers on the chromosome 21 study predicted their results could mean that there are as few as 40,000 genes in the entire human genome. "Someone from Incyte will probably show up and bet 150,000," one gambler said. Incyte Genomics predicted earlier this year that there could be as many as 140,000 genes in the human genome, whereas previous estimates were closer to 100,000. Companies like Incyte, Celera, and Human Genome Sciences might benefit financially if the number turns out to be higher. The more genes there are, the more potential patents they can file on them, and the more information they can sell in their genomic databases, the backbones of the business models of most genomics companies. Earlier in the day, Roest Crollius of Genoscope in Every, France presented his team's research comparing the genome of the T. nigroviridis fish to the human genome. By comparing the two genomes, Crollius predicted that there may be as few as 34,000 genes in the human genome. wired.com